Showing 8,901 - 8,920 results of 21,342 for search '(( significantly ((nn decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.59s Refine Results
  1. 8901

    Table 6_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx by Lei Zhang (38117)

    Published 2025
    “…Notably, both IgAN and MN patients showed a decrease in the abundance of certain specific microbial taxa. …”
  2. 8902

    Table 3_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx by Lei Zhang (38117)

    Published 2025
    “…Notably, both IgAN and MN patients showed a decrease in the abundance of certain specific microbial taxa. …”
  3. 8903

    Table 1_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx by Lei Zhang (38117)

    Published 2025
    “…Notably, both IgAN and MN patients showed a decrease in the abundance of certain specific microbial taxa. …”
  4. 8904

    Table 5_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx by Lei Zhang (38117)

    Published 2025
    “…Notably, both IgAN and MN patients showed a decrease in the abundance of certain specific microbial taxa. …”
  5. 8905

    Table 4_The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy.xlsx by Lei Zhang (38117)

    Published 2025
    “…Notably, both IgAN and MN patients showed a decrease in the abundance of certain specific microbial taxa. …”
  6. 8906

    Data Sheet 1_Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an in vitro study.docx by Ameya Joshi (1290186)

    Published 2025
    “…The non-specific inhibitor Vorinostat surprisingly promoted migration in the cells at its 2D IC50 value treatment, and none of the inhibitors was able to significantly decrease late resistance compared to untreated controls, indicating the need for the development of more potent HDAC inhibitors for monotherapy for GBM.…”
  7. 8907
  8. 8908
  9. 8909
  10. 8910
  11. 8911
  12. 8912
  13. 8913
  14. 8914
  15. 8915
  16. 8916
  17. 8917
  18. 8918
  19. 8919
  20. 8920